Results 101 to 110 of about 35,037 (252)

Seroepidemiology and molecular diversity of Leishmania donovani complex in Georgia [PDF]

open access: yes, 2016
Background Leishmaniasis includes multiple clinical syndromes, most notably visceral, cutaneous, and mucosal forms. Visceral leishmaniasis (VL), also known as kala-azar, is a potentially fatal disease endemic to large parts of Africa and Asia, and in ...
Adeishvili, Ekaterine   +15 more
core   +3 more sources

Antileishmanial Activities of Carvacrol Nanoencapsulate in Biopolymeric Nanoparticles

open access: yesChemistry &Biodiversity, Volume 22, Issue 9, September 2025.
The study obtained biopolymeric nanoparticles containing carvacrol (NPCar) and evaluated their anti‐leishmanial activity. NPCar obtained presented physicochemical characteristics due to its ideal nanometric size and zeta potential, and low polydispersity index.
Joyce Cordeiro Borges   +6 more
wiley   +1 more source

Application of kDNA as a molecular marker to analyse Leishmania infantum diversity in Portugal.

open access: yes, 2006
Around the Mediterranean basin Leishmania infantum is an important parasite causing canine leishmaniasis and visceral and cutaneous clinical forms in both immunocompetent and immunocompromised humans.
Almeida, Ana   +6 more
core   +1 more source

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. [PDF]

open access: yes, 2011
Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human ...
Aderie, Endashaw Mengistu   +6 more
core   +2 more sources

Can cutaneous leishmaniasis provoke a resurgence of kala-azar in the Indian subcontinent?

open access: yesBMC Infectious Diseases
Background The ongoing kala-azar elimination program in Nepal is based on the assumption of anthroponotic transmission of the protozoan parasite Leishmania donovani. This parasite species was recently also found in lesions of cutaneous leishmaniasis (CL)
Narayan Raj Bhattarai   +12 more
doaj   +1 more source

The epidemiology of Leishmania donovani infection in high transmission foci in India.

open access: yes, 2010
OBJECTIVE: Visceral Leishmaniasis (VL) is highly prevalent in Bihar, India. India and its neighbours aim at eliminating VL, but several knowledge gaps in the epidemiology of VL may hamper that effort.
Andersen, Elisabeth W   +10 more
core   +1 more source

Insights on adaptive and innate immunity in canine leishmaniosis [PDF]

open access: yes, 2016
Canine leishmaniosis (CanL) is caused by the parasite Leishmania infantum and is a systemic disease, which can present with variable clinical signs, and clinicopathological abnormalities.
Abi Abdallah   +19 more
core   +4 more sources

Current Perspectives on Leishmaniasis

open access: yesJournal of Gandaki Medical College, 2019
No abstract available.
KR Reddy
doaj   +1 more source

A Killing Disease Epidemic Among Displaced Sudanese Population Identified as Visceral Leishmaniasis. [PDF]

open access: yes, 1991
A fatal disease epidemic affected the Bentiu area in southern Sudan and led to a mass migration of the Nuer tribe searching for treatment. The initially available information revealed a high mortality rate due to a possible occurrence of tuberculosis ...
Chantal, B   +5 more
core   +2 more sources

Glycobiology of Leishmania donovani.

open access: yesThe Indian journal of medical research, 2006
Leishmania donovani, the causative organism of visceral leishmaniasis (VL) is one of the deadliest of the entire known Leishmania species. This protozoan parasite displays immense adaptability to survive under extremely harsh conditions. Cell surface glycoconjugates play a pivotal role in parasite virulence and infectivity.
Sumi, Mukhopadhyay, Chitra, Mandal
openaire   +1 more source

Home - About - Disclaimer - Privacy